First gene therapy to treat rare blood disease nears European approval
RUBY WALLAU FOR STAT
There are dozens of biotech and pharma companies developing gene therapies for rare diseases today, but Bluebird was an early pioneer.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario